https://www.digitaljournal.com/pr/news/newsfile/skye-bioscience-completes-enrollment-of-phase-1-clinical-trial-of-novel-cb1r-agonist-sbi-100-ophthalmic-emulsion
Skye Bioscience Completes Enrollment of Phase 1 Clinical Trial of Novel CB1R Agonist, SBI-100...